Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.

Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.

<h4>Background</h4>Mycobacterium ulcerans disease (Buruli ulcer) is a neglected tropical disease common amongst children in rural West Africa. Animal experiments have shown that tissue destruction is caused by a toxin called mycolactone.<h4>Methodology/principal findings</h4>...

Full description

Bibliographic Details
Main Authors:	Fred Stephen Sarfo, Richard O Phillips, Brian Rangers, Engy A Mahrous, Richard E Lee, Edward Tarelli, Kingsley B Asiedu, Pamela L Small, Mark H Wansbrough-Jones
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-01-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20052267/?tool=EBI

Similar Items

Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography.
by: Anita Wadagni, et al.
Published: (2015-11-01)

Mycobacterium ulcerans and other mycolactone-producing mycobacteria should be considered a single species.
by: Sacha J Pidot, et al.
Published: (2010-01-01)

Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana.
by: Heather Williamson, et al.
Published: (2014-01-01)

Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage.
by: Estelle Marion, et al.
Published: (2012-01-01)

Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient source.
by: Caroline Deshayes, et al.
Published: (2013-11-01)

Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans.
by: Cesar A López, et al.
Published: (2018-02-01)

IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection
by: Aloysius D. Loglo, et al.
Published: (2018-07-01)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
by: Louisa Warryn, et al.
Published: (2020-06-01)

Structure-activity relationship studies on the macrolide exotoxin mycolactone of Mycobacterium ulcerans.
by: Nicole Scherr, et al.
Published: (2013-01-01)

Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity.
by: Alvar Grönberg, et al.
Published: (2010-01-01)

Environmental Variations in Mycobacterium ulcerans Transcriptome: Absence of Mycolactone Expression in Suboptimal Environments
by: Daniel Sanhueza, et al.
Published: (2019-03-01)

Molecular Mechanisms Underpinning the Circulation and Cellular Uptake of Mycobacterium ulcerans Toxin Mycolactone
by: Bruno Tello Rubio, et al.
Published: (2021-09-01)

Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans.
by: Jean-Pierre Dangy, et al.
Published: (2016-06-01)

Responses to chemical cross-talk between the Mycobacterium ulcerans toxin, mycolactone, and Staphylococcus aureus
by: Laxmi Dhungel, et al.
Published: (2021-06-01)

Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone
by: Marie Robbe-Saule, et al.
Published: (2021-01-01)

Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
by: Hui Hong, et al.
Published: (2008-01-01)

The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.
by: Belinda S Hall, et al.
Published: (2014-04-01)

Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.
by: José B Gama, et al.
Published: (2014-08-01)

Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.
by: Paul J Converse, et al.
Published: (2014-01-01)

Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
by: Fred Stephen Sarfo, et al.
Published: (2013-01-01)

Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice.
by: Virginie Roupie, et al.
Published: (2014-01-01)

Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
by: Alexandra G Fraga, et al.
Published: (2012-01-01)

Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
by: Nicholas J Tobias, et al.
Published: (2009-01-01)

Immunopathogenesis of Mycobacterium ulcerans disease (Buruli ulcer)
by: Phillips, Richard Odame
Published: (2005)

Correction: Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
by: Nicholas J. Tobias, et al.
Published: (2010-02-01)

First cultivation and characterization of Mycobacterium ulcerans from the environment.
by: Françoise Portaels, et al.
Published: (2008-01-01)

Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay.
by: Michael Frimpong, et al.
Published: (2019-02-01)

Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.
by: Fred S Sarfo, et al.
Published: (2011-07-01)

Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports
by: Y. A. Amoako, et al.
Published: (2019-07-01)

Mycobacterium ulcerans DNA not detected in faecal samples from Buruli ulcer patients: results of a pilot study.
by: Fred S Sarfo, et al.
Published: (2011-01-01)

Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin.
by: Heather R Williamson, et al.
Published: (2012-01-01)

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
by: Mabel Sarpong-Duah, et al.
Published: (2017-07-01)

Investigating the mechanism behind the tissue necrosis in Mycobacterium ulcerans infection
by: Ogbechi, J.
Published: (2017)

Mycobacterium ulcerans Disease, Peru
by: Humberto Guerra, et al.
Published: (2008-03-01)

Translocating Mycobacterium ulcerans: An experimental model.
by: Nassim Hammoudi, et al.
Published: (2020-01-01)

Profiling Mycobacterium ulcerans with hsp65
by: Sylvia Cardoso Leão, et al.
Published: (2005-11-01)

Ongoing Genome Reduction in Mycobacterium ulcerans
by: Simona Rondini, et al.
Published: (2007-07-01)

Mycobacterium ulcerans Treatment Costs, Australia
by: Christina Drummond, et al.
Published: (2004-06-01)

Histopathologic Features of Mycobacterium ulcerans Infection
by: Jeannette Guarner, et al.
Published: (2003-06-01)

Buruli Ulcer : Mycobacterium Ulcerans Disease
Published: (2019)